Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients

NCT03017313 ·Status: COMPLETED

Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

NCT03658486 ·Status: COMPLETED ·Phase: NA

Long-Term Follow-Up in Patients With Prostate Cancer After Surgery

NCT03035500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients

NCT00127088 ·Status: SUSPENDED ·Phase: PHASE2

A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants

NCT02813408 ·Status: COMPLETED

PROSTACOX : Metastatic Prostate Chemotherapy

NCT00213694 ·Status: COMPLETED

Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment

NCT04890314 ·Status: COMPLETED

Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer

NCT02008058 ·Status: COMPLETED

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

NCT01957436 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations

NCT02705846 ·Status: RECRUITING

Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

NCT03611686 ·Status: ACTIVE_NOT_RECRUITING

Prostate Cancer Study of Patient Experiences

NCT07096596 ·Status: NOT_YET_RECRUITING

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

NCT07146113 ·Status: RECRUITING

Prostatic Cancer Versus Androgen Deficiency

NCT02235142 ·Status: COMPLETED ·Phase: NA

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

NCT01123434 ·Status: COMPLETED

Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database

NCT06902441 ·Status: COMPLETED

PROCARE - PROstate Cancer Real World Evidence Registry

NCT06835218 ·Status: RECRUITING

PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.

NCT02922218 ·Status: UNKNOWN

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

NCT02066961 ·Status: COMPLETED

Lifestyle Intervention in Patients With Metastatic Prostate Cancer

NCT05850182 ·Status: RECRUITING ·Phase: NA

Active Control of Prostatic Cancer With Criteria of Latence

NCT00921258 ·Status: TERMINATED

Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

NCT01953640 ·Status: ACTIVE_NOT_RECRUITING

Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

NCT02230059 ·Status: COMPLETED

Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State

NCT01560858 ·Status: COMPLETED

Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)

NCT05885009 ·Status: RECRUITING